SCHEMBL18013422

SCHEMBL18013422

COc1cnc(Br)cc1C(C)=O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTT P42858 2/20 0.46
CYP3A4 P08684 3/20 0.41
TSHR P16473 2/20 0.41
LCK P06239 1/20 0.41
FYN P06241 1/20 0.41
PTGDR2 Q9Y5Y4 1/20 0.41
CA9 Q16790 1/20 0.40
LMNA P02545 3/20 0.39
SRC P12931 2/20 0.39
TGFBR1 P36897 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
RAB9A P51151 2/20 0.37
MAPT P10636 1/20 0.37
NNMT P40261 1/20 0.37
ALK Q9UM73 1/20 0.36
ALDH1A1 P00352 3/20 0.36
HPGD P15428 1/20 0.36
MAPK1 P28482 1/20 0.36
KDM4E B2RXH2 1/20 0.36
HSD17B10 Q99714 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16333723 0.87 LCK (0.55) HTTTSHRLCKFYNCA9
SCHEMBL30390198 0.84 KDM4E (0.46) HTTTSHRLCKFYNCA9
SCHEMBL18512318 0.84 KDM4E (0.46) HTTTSHRLCKFYNCA9
SCHEMBL20601577 0.83 TSHR (0.40) HTTCYP3A4TSHRFYNPTGDR2
SCHEMBL22842606 0.80 HTT (0.47) HTTCYP3A4TSHRCA9LMNA
SCHEMBL18013428 0.80 HTT (0.47) HTTCYP3A4TSHRCA9LMNA
SCHEMBL23329394 0.79 MTNR1A (0.38) LCKFYNRAB9ANNMTKDM4E
SCHEMBL20855840 0.76 CYP3A4 (0.46) HTTCYP3A4TSHRPTGDR2CA9
SCHEMBL1977994 0.76 HTT (0.41) HTTCYP3A4TSHRPTGDR2CA9
SCHEMBL18361718 0.75 LCK (0.53) TSHRLCKFYNCA9NNMT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3255042-B1 HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME BEYONDBIO INC (KR) 2020-12-30 EP disclosed
WO-2016126085-A2 HETEROCYCLIC COMPOUND AND PHARMACEUTICAL COMPOSITION COMPRISING SAME 비욘드바이오주식회사 2016-08-11 WO disclosed